GENEVA, April 30 -- TACIT THERAPEUTICS, INC. (329 Oyster Point BlvdJLABS, 3rd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2024/051860) for "TRANS-SPLICING NUCLEIC ACID MOLECULES AND METHODS OF USE" on Oct 17, 2024. With publication no. WO/2025/085691, the details related to the patent application was published on Apr 24, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): NELLES, David Allen (c/o Tacit Therapeutics, Inc.329 Oyster Point BlvdJLABS, 3rd FloorSouth San Francisco, California 94080)
Abstract:
The present disclosure provides compositions, systems, ...